Professional
Added to YB: 2024-08-08
Pitch date: 2024-06-30
TWST [bullish]
Twist Bioscience Corporation
-35.95%
current return
Author Info
No bio for this author
Company Info
Twist Bioscience Corporation manufactures and sells synthetic DNA-based products. The company offers synthetic genes and gene fragments used in product development for therapeutics, diagnostics, chemicals/materials, food/agriculture, data storage, and various applications within academic research by biotech, pharma, industrial chemical, and agricultural companies, as well as academic labs; Oligo pools used in targeted NGS, CRISPR gene editing, mutagenesis experiments, DNA origami, DNA computing, data storage in DNA, and other applications; and immunoglobulin G proteins for customers focused on the pursuit of drug discovery and development.
Market Cap
$1.6B
Pitch Price
$48.29
Price Target
N/A
Dividend
N/A
EV/EBITDA
-16.66
P/E
-20.69
EV/Sales
3.93
Sector
Biotechnology
Category
growth
Artisan Small Cap Fund Added On Portfolio Holding: Twist Bioscience Corporation
TWST: DNA synthesis leader w/ silicon platform. Q2 standout, 25% rev growth, 48% order growth. Synthetic bio for biotech, diagnostics, agriculture, biofuels. Large, fast-growing market; Twist well-positioned. Added to position after strong earnings.
Read full article (1 min)